YM 60828

Known as: YM-60828, YM60828 
 

Topic mentions per year

Topic mentions per year

1997-2010
01219972010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Whereas heparin functions as an antithrombotic agent by promoting antithrombin III-based inhibition of thrombin and factor Xa… (More)
Is this relevant?
2003
2003
Compound YM-60828 was previously characterized in our laboratory as a potent, selective and orally-bioavailable Factor Xa (FXa… (More)
Is this relevant?
2002
2002
Since Factor Xa (FXa) is well known to play a central role in thrombosis and hemostasis, inhibition of FXa is an attractive… (More)
Is this relevant?
2002
2002
Factor Xa (FXa) is a serine protease which plays a pivotal role in the coagulation cascade. The inhibition of FXa has received… (More)
Is this relevant?
1998
1998
YM-60828 was found to potently inhibit human factor Xa following oral administration. YM-60828 showed high affinity for factor Xa… (More)
Is this relevant?
1998
1998
We examined the antithrombotic activity of a novel synthetic inhibitor of factor Xa, YM-60828, in an electrically-induced carotid… (More)
Is this relevant?
1998
1998
1. The effects of YM-60828, a newly synthesized factor Xa inhibitor, were investigated to analyse the relationship between its… (More)
Is this relevant?
1998
1998
The antithrombotic effects of a novel factor Xa inhibitor, YM-60828 ([N-[4-[(1-acetimidoyl-4-piperidyl)oxy]phenyl]-N-[(7-amidino… (More)
Is this relevant?
1998
1998
We examined the adjunctive effect of a novel factor Xa inhibitor, YM-60828, on vessel patency and blood loss from the operation… (More)
Is this relevant?
1997
1997
The antithrombotic effects of intravenous infusions of YM-60828 ([N-[4-[(1-acetimidoyl-4-piperidyl)oxy]phenyl]-N-[(7-amidino-2… (More)
Is this relevant?